# Safety, Tolerability and Pharmacokinetics of SAR113945 Following Intra-articular Administration in Patients With Knee Osteoarthritis

> **NCT01113333** · PHASE1 · COMPLETED · sponsor: **Sanofi** · enrollment: 40 (estimated)

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** placebo
- **DRUG:** SAR113945

## Key facts

- **NCT ID:** NCT01113333
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2011-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01113333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01113333, "Safety, Tolerability and Pharmacokinetics of SAR113945 Following Intra-articular Administration in Patients With Knee Osteoarthritis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01113333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*